Loganathan Gopalakrishnan, Venugopal Subhashree, Balamurugan Appakalai N
Department of Surgery, Clinical islet cell laboratory, Cardiovascular Innovation Institute, University of Louisville, Louisville, KY USA.
School of Biosciences and Technology, Vellore Institute of Technology, Vellore, India.
J Diabetes Metab Disord. 2020 Apr 13;19(1):381-389. doi: 10.1007/s40200-020-00519-y. eCollection 2020 Jun.
Human islet isolation requires a defined collagenase-protease enzyme combination for obtaining a successful islet yield. While different islet laboratories use different enzyme combinations, a systematic methodology to identify optimal enzyme combinations and their concentrations within a single donor pancreas has not been tested. In this study, we designed a trisected pancreas model to test efficacy of three clinical grade enzyme blends (VitaCyte, Roche, SERVA) within a single pancreas.
Islet isolations were performed using brain-dead donor pancreases ( = 15) applying the enzyme-related design of experiments (DOEs) and the trisected model approach. After trimming, split each pancreas into three individual lobes (head, body, tail). As per the DOEs, the lobes were altered between different experiments, to minimize anatomical bias. Islets isolated from each lobe (27 lobes totally) were subjected to functional assessments. Insulin staining and islet area fraction were determined for tissue sections obtained from each lobe.
Utilizing the trisected model, we identified that the collagenase dose from three different vendors did not affect the pancreas digestion and islet yield, but islet morphology after isolation with the neutral protease and BP-protease was better than thermolysin. In addition, the head lobe yielded a lower islet mass and higher tissue volume compared to other two lobes, irrespective of enzyme combination used.
This study demonstrates that the trisected model is a promising methodology in assessing donor and isolation associated parameters. Based on this study, we conclude that the donor characteristics and an optimal enzyme dose play a critical role in achieving higher islet yields.
人胰岛分离需要特定的胶原酶 - 蛋白酶组合以获得成功的胰岛产量。虽然不同的胰岛实验室使用不同的酶组合,但尚未测试在单个供体胰腺中确定最佳酶组合及其浓度的系统方法。在本研究中,我们设计了一个三分胰腺模型,以测试三种临床级酶混合物(VitaCyte、罗氏、SERVA)在单个胰腺中的效果。
使用脑死亡供体胰腺(n = 15),采用与酶相关的实验设计(DOEs)和三分模型方法进行胰岛分离。修剪后,将每个胰腺分成三个单独的叶(头、体、尾)。根据实验设计,在不同实验中改变叶的分组,以尽量减少解剖学偏差。对从每个叶分离的胰岛(共27个叶)进行功能评估。对从每个叶获得的组织切片进行胰岛素染色和胰岛面积分数测定。
利用三分模型,我们发现来自三个不同供应商的胶原酶剂量不影响胰腺消化和胰岛产量,但用中性蛋白酶和BP - 蛋白酶分离后的胰岛形态优于嗜热菌蛋白酶。此外,无论使用何种酶组合,头叶产生的胰岛质量较低,组织体积较高。
本研究表明,三分模型是评估供体和分离相关参数的一种有前景的方法。基于本研究,我们得出结论,供体特征和最佳酶剂量在实现更高的胰岛产量方面起着关键作用。